Form 4/A for ZURA Zura Bio Ltd
Accepted 2024-09-06 00:00:00 ET · period of report 2024-04-22 · accession 0001415889-24-023030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AI | 2024-09-06 | 2024-04-22 | ZURA | Sidhu Someit | Dir | A - Grant | $3.13 | +1.19M | 1.19M | New | +$3.72M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A ordinary shares | 2024-04-22 | A | A | 1,186,901 | $3.13 | 1,186,901 | I By LLC | — | — | (F2) These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and Pegasus LLC at a purchase price of $3.13 per share. (F3) These shares were acquired by Pegasus LLC. The Reporting Person is the sole member and beneficial owner of the limited liability company interests of Pegasus LLC. |